Biologic Drugs

Apr 02, 2013
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A Q&A with Tony Hitchcock, head of manufacturing at Cobra Biologics.
Apr 02, 2013
Pharmaceutical Technology
Sound policies are needed to govern the substitution of interchangeable biologics.
Mar 13, 2013
Pharmaceutical Technology
Matthieu Egloff, product director with ATMI LifeSciences, discusses the need for larger, special reactors that can provide the necessary conditions for the production of fragile cells on a larger scale.
Mar 06, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
Roche and BioLamina have entered into a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research. The collaboration will assess laminin-based in-vitro cell culture matrices that can offer physiological microenvironments for living cells.
Mar 02, 2013
Pharmaceutical Technology
Companies risk drowning in alphabet soup if the latest three-letter acronym improvement strategy isn't clearly linked to business strategy.
Feb 27, 2013
Pharmaceutical Technology
Kevin Ott, executive director of the Bio-Process Systems Alliance, discusses the latest trends and issues surrounding single-use technologies and the role of his association.
Feb 20, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Merck and Samsung Bioepis have formed an agreement to develop and commercialize multiple prespecified and undisclosed biosimilar candidates.
Feb 02, 2013
Pharmaceutical Technology
The share of biologic-based drugs in the global pharmaceutical market is on the rise.
Jan 02, 2013
Pharmaceutical Technology
Is process-centered organization in biopharmaceutical manufacturing a stepping stone or a stumbling block?
Nov 26, 2012
ePT--the Electronic Newsletter of Pharmaceutical Technology
Novartis announced that it has received FDA approval for a seasonal influenza vaccine produced in cell culture, the first seasonal vaccine produced by this method to be approved in the US.
native1_300x100
lorem ipsum